On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
Josh Moon has been appointed Chief Operating Officer (COO) at Creative Testing Solutions (CTS), effe...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...